Clinical Trial

Tau PET/CT in Various Tau-Related Disease Patients

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 18F-S16/T807 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-14; most recent amendment 2025-02-07.
Trial Details
NCT Number NCT06690983
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions Tauopathies, Neurodegenerative Diseases, Neurodegeneration
Enrollment 500 participants
Start Date 2018-08-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11